跳到內容

腫瘤科

多面向治療技術,多專科科際合作及個人化的醫療處置

Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. (開啟新視窗)

Atabek U, Spence RK, Pello M, Alexander J, Camishion R.

出處‎: Arch Surg 1992;127(3):349-51.

檢索‎: PubMed 1347993

https://www.ncbi.nlm.nih.gov/pubmed/1347993 (開啟新視窗)

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (開啟新視窗)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

出處‎: J Surg Oncol 2007;96(3):249-53.

檢索‎: PubMed 17443725

DOI碼‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (開啟新視窗)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (開啟新視窗)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

出處‎: Transfusion 2016;56(10):2438-42.

檢索‎: PubMed 27385671

DOI碼‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (開啟新視窗)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (開啟新視窗)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

出處‎: Oncologist 2016;21(3):327-32.

檢索‎: PubMed 26865590

DOI碼‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (開啟新視窗)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (開啟新視窗)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

出處‎: J Am Coll Surg 2013;217(6):1101-7.

檢索‎: PubMed 23880361

DOI碼‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (開啟新視窗)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (開啟新視窗)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

出處‎: Leuk Res Rep. 2022 25;18:100355.

檢索‎: PubMed 36338830

DOI碼‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (開啟新視窗)